In the industrial sectors, high filters are installed in clean rooms to control the buildup of airborne dust and gases. A HEPA filter gathers hazardous particles such as pet dander, dust mites, pollen, and tobacco smoke by forcing air through a small mesh. According to the Asthma and Allergy Foundation of America (AAFA), allergic diseases, such as asthma, are the fifth most prevalent chronic illnesses in the US amongst all ages, and the third most common chronic illness among individuals under the age of 18 years. The higher incidence of allergies and asthma in the US is likely to emerge as a key driver of the U.S. HEPA (High Efficiency Particulate Air) vacuum filters market.
As per statistics, the incidence of airborne infectious illnesses, asthma, and pulmonary allergies in the US are increasing year after year, which is expected to raise demand for HEPA vacuum filters. These filters, as per a press release from the American Thoracic Society, are a highly effective intervention since they are affordable to buy and capable of eliminating microscopic particles that humans can inhale. The U.S. HEPA (High Efficiency Particulate Air) vacuum filters market is likely to gain from growing awareness among consumers about airborne infectious illnesses. This is in addition to the rising prevalence of respiratory allergies.
The U.S. HEPA (High Efficiency Particulate Air) vacuum filters market takes a comprehensive look at the industry. The study covers the history of the market, as well as the most recent trends and top forecasts for the U.S. HEPA vacuum filters market. A financial analysis and business strategy of the top firms participating in the U.S. HEPA (High Efficiency Particulate Air) vacuum filters market are also included in the study.
Rise in the Prevalence of Asthma and Allergies to Drive Revenue Generation Opportunities in the Market
The rising frequency of allergies and asthma caused by common pollutants such as pollen and dust is estimated to drive the demand for HEPA vacuum filters in the US. Around one in every five Americans, or over 60 million people, suffers from some kind of allergies or asthma. Since HEPA vacuum filters are so effective at removing even minute allergens like pollen, they are in great demand. It is expected that by 2025, the number of individuals suffering from allergies and asthma in the US is predicted to reach over 100 million, increasing the significance of this aspect in the U.S. HEPA (High Efficiency Particulate Air) vacuum filters market.
The need for improved and powerful HEPA vacuum filters has been spurred by growing people's awareness about the threat of infectious illnesses, which has been supported by government measures. Due to the rising quantity of air pollution in the US, airborne diseases have become a big hazard, and individual end users and also hospitals have begun to deploy HEPA vacuum filter systems to lower the occurrence of airborne diseases.
Rising Demand for Product Innovation and Affordable Cost to Drive the Market in the US
Despite the demonstrated advantages of HEPA vacuum filters over traditional air filter technology, the former's rising costs are a key constraint in the U.S. HEPA (High Efficiency Particulate Air) vacuum filters market. Companies have failed to reach a sustainable cost-price balance due to high technological competence of HEPA vacuum filters. Companies in the US is likely to find it simpler to offer HEPA vacuum filters at reduced prices as demand from the healthcare industry develops.
However, considering product innovation is a key difference in the consolidated U.S. HEPA (High Efficiency Particulate Air) vacuum filters market, companies are expected to keep on adding features to their products, resulting in higher costs. In the next few years to come, this is expected to emerge as a critical problem in the U.S. HEPA (High Efficiency Particulate Air) vacuum filters market, as companies are expected to combine rising demand for features such as organic volatile compound elimination with the requirement to lower prices in order to raise sales volume.